Results 211 to 220 of about 251,619 (354)

432 Characteristics and Predictors of Tramadol Misuse Results from the 2015 National Survey on Drug Use and Health [PDF]

, 2017
Saumitra V. Rege, Christopher P. Holstege   +1 more
openalex   +1 more source

Psychotropic medication use among community dwellers with and without Parkinson's disease – A nationwide cohort study

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims We studied the prevalence of psychotropic use and psychotropic polypharmacy in persons with Parkinson's disease (PD) during a 10‐year follow‐up, because longitudinal studies on this topic are scarce although non‐motor symptoms of PD are often treated with psychotropics.
Noora Nieminen, Anna‐Maija Tolppanen, Valtteri Kaasinen, Marjaana Koponen, Sirpa Hartikainen   +4 more
wiley   +1 more source

Covid-19 interface with drug misuse and substance use disorders. [PDF]

Neuropharmacology, 2021
Cisneros IE, Cunningham KA.
europepmc   +1 more source

The Misuse Defense in Drug Products Liability Cases [PDF]

, 1988
Grant, Jonathan E.
core   +1 more source

HLA genotype testing for carbamazepine, oxcarbazepine and eslicarbazepine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, EarlyView.
Carbamazepine is licensed in the United Kingdom for the treatment of epilepsy, bipolar disorder and trigeminal neuralgia. The related compounds oxcarbazepine and eslicarbazepine are licensed for the treatment of epilepsy. These drugs can cause immune‐mediated hypersensitivity reactions, which typically affect the skin, and can be of variable severity ...
Lucy Galloway, Cinzia Dello Russo, Nicholas Bass, Elvira Bramon, Helen Cross, Natalie Curley, Sarah Curran, Helen Davies, Jana De Villiers, William Evans, Bernhard Frank, Alice Groves, Judith Hayward, Jon Higham, Dyfrig A. Hughes, Shwe Sin Kyaw, Anthony G. Marson, Ailsa McLellan, Seth Mensah, Francis O'Neill, Jane Sargison, Sanjay M. Sisodiya, Jill Swan, Joanna M. Zakrewska, Munir Pirmohamed   +24 more
wiley   +1 more source

Prospective associations of alcohol and drug misuse with suicidal behaviors among US Army soldiers who have left active service. [PDF]

Psychol Med
Campbell-Sills L, Sun X, Kessler RC, Ursano RJ, Jain S, Stein MB.   +5 more
europepmc   +1 more source

The Initiation and Developmental Course of Prescription Drug Misuse Among High School Athletes During the Transition Through Young Adulthood. [PDF]

Am J Epidemiol, 2022
Veliz PT, Schulenberg JE, Zdroik J, Werner KS, McCabe SE.   +4 more
europepmc   +1 more source

Exploring the consequences of how Scotland interprets the UK Misuse of Drugs Act 1971

, 2012
John McPhee, Colin R. Martin, Anthony Sneider   +2 more
openalex   +2 more sources

Increasing the reporting of adverse drug reaction‐related hospitalizations using an ICD‐10‐based identification workflow: A multicentre study from Switzerland

British Journal of Clinical Pharmacology, EarlyView.
Background Reporting adverse drug reactions (ADRs) is essential for drug safety. In Switzerland, healthcare professionals are legally required to report serious and unlabelled ADRs, yet under‐reporting remains widespread. We tested a novel method to increase reporting of ADR‐related hospitalizations.
Georgia Anita Weber, Sophie‐Charlotte Bartel, Michael Boch, Christoph Rosen, Michael Bodmer, Balthasar Luzius Hug, Thomas Stammschulte, Patrick E. Beeler   +7 more
wiley   +1 more source

Empowerment in prevention: a qualitative inquiry into Black girl-centred strategies for reducing HIV/STI and drug misuse risk. [PDF]

Sex Reprod Health Matters
Opara I, Asabor E, Rutledge J, Brooks Stephens JR, Cayo S, Duran-Becerra B, Abrams J.   +6 more
europepmc   +1 more source